Skip to main content
OpenTrials
Completed

NCT Number: NCT03133455

Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia

Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.

The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens Picardie

Amiens, Picardie, 80054, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • FM Criteria of the American College of Rheumatology ACR 1990.
  • Major Patients
  • free and informed consent signed
  • stable treatment for at least one month
  • Native French speaker
  • Patient covered by health insurance.

Exclusion criteria

  • Patient deprived of liberty or protected major (under guardianship or curatorship)

Treatment and study plan

Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.

Other

Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.

Primary outcomes

  1. Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire

    Time frame: 1 hour

    Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: PRFM-1

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Apr 28, 2017
Registry last updated
Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.